Hemoglobin A1c determination in the A1C-Derived Average Glucose (ADAG) study

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 11, 2008, Pages 1617-1623

  Lenters Westra, Erna ^a,b,c   Slingerland, Robbert J ^a,b  

^a Isala Klinieken ^*  (Netherlands)

^b European Reference Laboratory for Glycohemoglobin   (Netherlands)

^c ISALA HOSPITAL   (Netherlands)

Author keywords

Glycohemoglobin; HbA1c; IFCC reference system; International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) primary reference method; Secondary reference material

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL CHEMISTRY; CLINICAL LABORATORY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PRIORITY JOURNAL; REFERENCE VALUE; BLOOD; CALIBRATION; METABOLISM; METHODOLOGY; STANDARD; STATISTICAL MODEL; STATISTICS;

BLOOD GLUCOSE; CALIBRATION; CLINICAL CHEMISTRY TESTS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; REFERENCE VALUES;

EID: 56549102839     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.322     Document Type: Article

References (26)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complication in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. N Engl J Med 1993;329:978-86.
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1988;352:837-53.
3. Little RR, Rohlfing CL, Wiedmeyer H-M, Myers GL, Sacks DB, Goldstein DE. The National Glycohemoglobin Standardization Program (NGSP): a five-year progress report. Clin Chem 2001;47:1985-92.
4. Little RR, Glycated haemoglobin standardization. National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med 2003;41:1191-9.
5. Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem 2002;40:78-89.
6. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, et al.: IFCC Working Group on HbA1c Standardization, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004;50:166-74.
7. Miedema K. Towards worldwide standardisation of HbA1c determination. Diabetologia 2004;47:1143-8.
8. International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Scientific Division, Mosca A, Goodall I, Hoshino T, Jeppson JO, et al. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med 2007;45:1077-80.
9. Panteghini M, John WG: IFCC Scientific Division. Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward. Clin Chem Lab Med 2007;45:942-4.
10. Consensus statement on the worldwide standardization of haemoglobin A1c measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine and the International Diabetes Federation. Clin Chem 2007;53:1562-4.
11. Weykamp C, John WG, Mosca A, Hoshino T, Little R, Jeppson JO, et al. The IFCC Reference Measurement System for HbA1c: A 6-year progress report. Clin Chem 2008;54:240-8.
12. Hanas R. Psychological impact of changing the scale of reported HbA(1c) results affects metabolic control. Diabetes Care 2002;25:2110-1.
13. Sacks DB. Global harmonization of hemoglobin A1c. Clin Chem 2005;51:681-3.
14. Report of the ADA/EASD/IDF Working Group of the HbA1c Assay, London, UK, January 2004. Diabetologia 2004;47:R53-4.
15. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, for the A1c-Derived Average Glucose (ADAG) Study Group. Translating the A1c assay into estimated average glucose values. Diabetes Care 2008;31:1-6.
16. IFCC Working Group HbA1c. IFCC monitoring programme. www.ifcchba1c.net. Accessed March 27, 2008.
17. Little RR, Rohlfing CL, Tennill AL, Conolly S, Hanson S. Effects of sample storage conditions on glycated haemoglobin measurement: evaluation of five different high performance liquid chromatography methods. Diabetes Technol Ther 2007;9:36-42.
18. Thomas LB, Agosti SJ, Man MA, Mastorides SM. Screening for hemoglobinopathies during routine haemoglobin A1c testing using the Tosoh G7 glycohemoglobin analyzer. Ann Clin Lab Sci 2007;37:251-5.
19. Schendl WJ, Lahousen T, Lang T, Lipp RW, Yonehara S, Fukunaga S, et al. Determination of glycated haemoglobin in clinically silent haemoglobin variants. Diabetes Metab Res Rev 2004;20:460-5.
20. Bry L, Chen PC, Sacks DB. Effects of haemoglobin variants and chemically modified derivates on assays for glycohemoglobin. Clin Chem 2001;47:153-63.
21. Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M, Lipp RW, Krejs GJ. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care 2000;23:339-44.
22. International Organization for Standardization. In vitro diagnostic medical devices-measurements of quantities in samples of biological origin-metrological traceability of values assigned to calibrators and control material. ISO 17511. Geneva, Switzerland: International Organization for Standardization, 2003.
23. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Off J L 1998;331:1-37.
24. Rhoads DG. EP evaluator release 8. DG Rhoads Associates Inc. www.dgrhoads.com. Accessed March 27, 2008.
25. Deming WE. Statistical adjustments of data. New York: Wiley, 1943:184 pp.
26. Goodall I, Colman P, Schneider H, McLean M, Barker G. Desirable performance standards for HbA1c analysis: precision, accuracy and standardisation. Clin Chem Lab Med 2007;45:1083-97.